Impact of BerriQi® Boysenberry and apple beverage on lung health of individuals with sarcoidosis.

Not Applicable

• Conditions: Pulmonary sarcoidosis; Respiratory - Other respiratory disorders / diseases; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12620001050943
• Lead Sponsor: Anagenix Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-15
• Last Update Posted: 19 October 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

a.They are an adult aged 18-65
b.They have had biopsy-proven pulmonary sarcoidosis for at least one year
c.They are on stable medication (e.g. prednisone, other, or none) dose for at least 4 weeks prior to recruitment, and unlikely to change medication during the course of this study
d.They are not currently participating in another clinical interventional study
e.They will provide written informed consent
f.They agree to avoid eating other berry fruits or foods likely to contain berry fruit for the duration of the study.

Exclusion Criteria

a.Current or prior (previous four weeks) respiratory tract infection
b.Current or prior eating disorder (e.g. anorexia nervosa, bulimia) that would interfere with consumption and/or absorption of the investigational product
c.Food allergy or intolerance that would compromise compliance with the study protocol, including berry fruits and apples

Study & Design

• Study Type: Interventional
• Study Design: Not specified